1. Home
  2. BLRX vs WETH Comparison

BLRX vs WETH Comparison

Compare BLRX & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • WETH
  • Stock Information
  • Founded
  • BLRX 2003
  • WETH 1992
  • Country
  • BLRX Israel
  • WETH China
  • Employees
  • BLRX N/A
  • WETH N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • WETH
  • Sector
  • BLRX Health Care
  • WETH
  • Exchange
  • BLRX Nasdaq
  • WETH Nasdaq
  • Market Cap
  • BLRX 12.1M
  • WETH 10.9M
  • IPO Year
  • BLRX 2011
  • WETH N/A
  • Fundamental
  • Price
  • BLRX $5.25
  • WETH $0.96
  • Analyst Decision
  • BLRX Strong Buy
  • WETH
  • Analyst Count
  • BLRX 2
  • WETH 0
  • Target Price
  • BLRX $19.00
  • WETH N/A
  • AVG Volume (30 Days)
  • BLRX 1.9M
  • WETH 44.0K
  • Earning Date
  • BLRX 05-27-2025
  • WETH 06-13-2025
  • Dividend Yield
  • BLRX N/A
  • WETH N/A
  • EPS Growth
  • BLRX N/A
  • WETH N/A
  • EPS
  • BLRX N/A
  • WETH 0.34
  • Revenue
  • BLRX $22,340,000.00
  • WETH $41,024,264.00
  • Revenue This Year
  • BLRX N/A
  • WETH N/A
  • Revenue Next Year
  • BLRX N/A
  • WETH N/A
  • P/E Ratio
  • BLRX N/A
  • WETH $2.78
  • Revenue Growth
  • BLRX 91.68
  • WETH 2.86
  • 52 Week Low
  • BLRX $2.30
  • WETH $0.76
  • 52 Week High
  • BLRX $35.60
  • WETH $3.62
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 84.90
  • WETH 42.62
  • Support Level
  • BLRX $3.32
  • WETH $0.94
  • Resistance Level
  • BLRX $3.97
  • WETH $1.08
  • Average True Range (ATR)
  • BLRX 0.46
  • WETH 0.09
  • MACD
  • BLRX 0.14
  • WETH 0.01
  • Stochastic Oscillator
  • BLRX 47.06
  • WETH 25.28

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.

Share on Social Networks: